162 related articles for article (PubMed ID: 1848269)
21. Restricted junctional diversity of T cell receptor delta gene rearrangements expressed in systemic lupus erythematosus (SLE) patients.
Olive C; Gatenby PA; Serjeantson SW
Clin Exp Immunol; 1994 Sep; 97(3):430-8. PubMed ID: 8082298
[TBL] [Abstract][Full Text] [Related]
22. Genotypic analysis of cutaneous T-cell lymphoma: a comparative study of Southern blot analysis with polymerase chain reaction amplification of the T-cell receptor-gamma gene.
Curcó N; Servitje O; Llucià M; Bertran J; Limón A; Carmona M; Romagosa V; Peyrí J
Br J Dermatol; 1997 Nov; 137(5):673-9. PubMed ID: 9415223
[TBL] [Abstract][Full Text] [Related]
23. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping.
Bakels V; van Oostveen JW; Preesman AH; Meijer CJ; Willemze R
J Clin Pathol; 1998 Feb; 51(2):154-8. PubMed ID: 9602691
[TBL] [Abstract][Full Text] [Related]
24. Molecular staging of cutaneous T-cell lymphoma: evidence for systemic involvement in early disease.
Veelken H; Wood GS; Sklar J
J Invest Dermatol; 1995 Jun; 104(6):889-94. PubMed ID: 7769255
[TBL] [Abstract][Full Text] [Related]
25. A rapid polymerase chain reaction-based technique for detecting clonal T-cell receptor gene rearrangements in cutaneous T-cell lymphomas of both the alpha beta and gamma delta varieties.
Yu RC; Alaibac M
Diagn Mol Pathol; 1996 Jun; 5(2):121-6. PubMed ID: 8727099
[TBL] [Abstract][Full Text] [Related]
26. Angioimmunoblastic lymphadenopathy with dysproteinemia and dermal T-cell lymphoma.
Yu RC; Schofield J; Alaibac M; Jones RR; Chu AC
Cancer; 1994 Sep; 74(6):1801-7. PubMed ID: 8082083
[TBL] [Abstract][Full Text] [Related]
27. Atypical cutaneous lymphocytic infiltrate and a role for quantitative immunohistochemistry and gene rearrangement studies.
Fucich LF; Freeman SF; Boh EE; McBurney E; Marrogi AJ
Int J Dermatol; 1999 Oct; 38(10):749-56. PubMed ID: 10561046
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor V beta 2 gene usage in microscopic polyarteritis.
Simpson IJ; Skinner MA; Geursen A; Peake JS; Abbott WG; Fraser JD; Lockwood CM; Tan PL
Clin Exp Immunol; 1995 Aug; 101(2):220-6. PubMed ID: 7544245
[TBL] [Abstract][Full Text] [Related]
29. T-cell receptor V beta-family usage in primary cutaneous and primary nodal T-cell non-Hodgkin's lymphomas.
Preesman AH; Hu HZ; Tilanus MG; de Geus B; Schuurman HJ; Reitsma R; van Wichen DF; van Vloten WA; de Weger RA
J Invest Dermatol; 1992 Nov; 99(5):587-93. PubMed ID: 1331246
[TBL] [Abstract][Full Text] [Related]
30. Gene rearrangements and T-cell lymphomas.
Terhune MH; Cooper KD
Arch Dermatol; 1993 Nov; 129(11):1484-90. PubMed ID: 8239705
[TBL] [Abstract][Full Text] [Related]
31. T cell receptor alpha and beta gene expression in a murine antigen-specific T suppressor lymphocyte clone with cytolytic potential.
Heuer J; Degwert J; Pauels HG; Kölsch E
J Immunol; 1991 Jan; 146(2):775-82. PubMed ID: 1846162
[TBL] [Abstract][Full Text] [Related]
32. DNA sequence analysis of interlocus recombination between the human T-cell receptor gamma variable (GV) and beta diversity-joining (BD/BJ) sequences on chromosome 7 (inversion 7).
Ballinger SW; Judice SA; Nicklas JA; Albertini RJ; O'Neill JP
Environ Mol Mutagen; 2002; 40(2):85-92. PubMed ID: 12203400
[TBL] [Abstract][Full Text] [Related]
33. Malignant and normal T cells show random use of T-cell receptor alpha chain variable regions in patients with cutaneous T-cell lymphoma.
Longley J; Tyrrell L; Lu SZ; Farrell J; Ding TG; Yan S; Sallee D; Heald P; Berger C; Tigelaar R
J Invest Dermatol; 1995 Jul; 105(1):62-4. PubMed ID: 7615977
[TBL] [Abstract][Full Text] [Related]
34. T-cell receptor V beta gene expression differs in tumor-infiltrating lymphocytes within primary and metastatic melanoma.
Nitta T; Bell R; Okumura K; Sato K; Steinman L
Cancer Res; 1991 Oct; 51(20):5565-9. PubMed ID: 1655255
[TBL] [Abstract][Full Text] [Related]
35. [How useful is the study of the T-cell repertoire in cutaneous T-cell lymphomas?].
Ingen-Housz Oro S; Musette P
Ann Dermatol Venereol; 2000 Oct; 127(10):862-4. PubMed ID: 11060399
[No Abstract] [Full Text] [Related]
36. Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation.
Dippel E; Assaf C; Hummel M; Schrag HJ; Stein H; Goerdt S; Orfanos CE
J Pathol; 1999 Jun; 188(2):146-54. PubMed ID: 10398157
[TBL] [Abstract][Full Text] [Related]
37. A single universal primer for the T-cell receptor (TCR) variable genes enables enzymatic amplification and direct sequencing of TCR beta cDNA of various T-cell clones.
Obata F; Tsunoda M; Ito K; Ito I; Kaneko T; Pawelec G; Kashiwagi N
Hum Immunol; 1993 Mar; 36(3):163-7. PubMed ID: 8320135
[TBL] [Abstract][Full Text] [Related]
38. Polymerase chain reaction amplification analyses of clonality in T-cell malignancy including peripheral T-cell lymphoma.
Hodges E; Edwards SE; Howell WM; Smith JL
Leukemia; 1994 Feb; 8(2):295-8. PubMed ID: 8309253
[TBL] [Abstract][Full Text] [Related]
39. Novel analysis of minimal residual disease in leukemia with TCR beta rearrangement--detection of monoclonality by single strand conformation polymorphism and PCR using a clonotype primer of leukemic T cell receptor beta-chain RNA.
Hanawa H; Koike T; Sakaue M; Kishi K; Shibata A; Abo T
Leuk Res; 1997 Mar; 21(3):201-10. PubMed ID: 9111164
[TBL] [Abstract][Full Text] [Related]
40. Conserved nucleotide sequences at the 5' end of T cell receptor variable genes facilitate polymerase chain reaction amplification.
Broeren CP; Verjans GM; Van Eden W; Kusters JG; Lenstra JA; Logtenberg T
Eur J Immunol; 1991 Mar; 21(3):569-75. PubMed ID: 2009906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
